NMN (Nicotinamide Mononucleotide)

Products commonly supply 250 to 500 mg per day. No dose has been shown to produce a health benefit in people: the one study cited on this page measured NAD levels in the blood over 14 days and did not measure energy, aging or metabolic health. Higher doses have not been shown to do more.

NMN (nicotinamide mononucleotide) is a precursor the body uses to make NAD+, a coenzyme central to energy metabolism and cellular repair that declines with age. It is marketed for healthy aging, energy and metabolic support, but the research cited here shows only that it raises NAD in the blood. No cited human study has tested whether that makes anyone feel more energetic, age more slowly or become metabolically healthier.

NMN and NR (nicotinamide riboside) are both NAD+ precursors and closely related. NR has more published human trials, while NMN is one step closer to NAD+. In a 14-day randomised study in 65 healthy adults, NMN and NR raised circulating NAD to a comparable degree, while plain nicotinamide did not. On that one measure the two look interchangeable, so price and product quality are reasonable ways to choose between them.

Short-term human studies suggest NMN is generally well tolerated at common doses. Long-term safety data is very limited; the study cited on this page ran only 14 days. On regulation, the FDA said in November 2022 that NMN was excluded from the dietary supplement definition, then reversed that in letters dated 29 September 2025 confirming NMN may be sold as a dietary supplement. It is still a new dietary ingredient, meaning each company must file a premarket notification, so quality and sourcing matter. Check with your doctor if pregnant, breastfeeding, or on medication.

NMN (nicotinamide mononucleotide) is a precursor that the body uses to make NAD+, a coenzyme central to energy metabolism and cellular repair whose levels decline with age. This has made NMN a popular longevity supplement, but the human research is much thinner than the marketing suggests.

The clinically studied dose is 250 to 500 mg/day is the usual commercial range. The only study cited on this page ran 14 days and measured blood NAD levels, so no dose has been linked to a health benefit. Always follow the product label and check with a healthcare provider for personal advice.

For most healthy adults, NMN is well tolerated at studied doses. Reported effects can include: Well tolerated in the short studies done so far; the one study cited here gave NAD boosters to 65 healthy adults for 14 days Mild nausea or GI discomfort reported by some users at higher doses It may also interact with some medications. NMN is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Possible interactions include: No established drug interactions — emerging safety data Theoretically, may interact with medications metabolized through SIRT1/NAD+ pathways If you take prescription medication, check with a pharmacist or doctor before using it.

NutraSmarts rates the evidence for NMN as Preliminary (1 out of 5). It is backed by 2 clinical trials and 1 cited reference summarized on this page. A higher rating reflects more, larger, and better-designed human studies.